Fatma Bahar Matusik is a pharmacist who is specialized in Pharmacotherapy in Southington, Connecticut. Patients can reach her at 80 Devonshire Dr, Southington or contact her on 860-305-0384. Active license number of Fatma Bahar Matusik is PCT.9570 for Pharmacotherapy in Connecticut. Fatma Bahar Matusik is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Fatma Bahar Matusik speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Fatma Bahar Matusik are as mentioned below.
NPI Number:
1770997736
NPI Enumeration Date:
18 Jun, 2014
NPI Last Update On:
18 Jun, 2014
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Fatma Bahar Matusik are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
PCT.9570
Connecticut
Primary
Pharmacist
PCT.9570
Connecticut
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
80 Devonshire Dr, Southington, Connecticut
Zip:
06489-4239
Phone Number:
860-305-0384
Fax Number:
--
Patients can reach Fatma Bahar Matusik at 80 Devonshire Dr, Southington, Connecticut or can call on phone at 860-305-0384.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.